Adverum to Present Data from ADVM-022 Clinical Trials at Upcoming Medical Conferences
REDWOOD CITY, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a…
REDWOOD CITY, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) — Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a…
Proven commercial leader with broad global experience in building and running commercial organizations and successfully…
Partnership to improve biodiversity research, accelerate conservation with actionable and accurate genomic data MENLO PARK,…
Study expected to be completed in the first half of 2022, with the goal to…
FLORHAM PARK, N.J., Sept. 27, 2021 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (“PDS Biotech” or…
NEVE ILAN, Israel, Sept. 27, 2021 (GLOBE NEWSWIRE) — NANO-X IMAGING LTD (“Nanox” or the “Company,”…
WESTLAKE VILLAGE, Calif., Sept. 27, 2021 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage…
HOUSTON, Sept. 27, 2021 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical…
SAN DIEGO, Sept. 27, 2021 (GLOBE NEWSWIRE) — Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision…
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Sept. 27, 2021 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation…
CRANBURY, N.J., Sept. 27, 2021 (GLOBE NEWSWIRE) — Rafael Pharmaceuticals, Inc. (“Rafael” or the “Company”),…
HOUSTON, Sept. 27, 2021 (GLOBE NEWSWIRE) — Tvardi Therapeutics (“Tvardi”) today announced that Fierce Biotech…
SAN DIEGO, Sept. 27, 2021 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce” or the “Company”)…
SAN DIEGO, Sept. 27, 2021 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology…
VANCOUVER, British Columbia, Sept. 27, 2021 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the…
NEW YORK, Sept. 27, 2021 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical…
Vonoprazan 20 mg demonstrated significantly greater acid suppressive effects over the 7-day study period compared…
GW-Led Research uses SeqLL’s tSMS® platform to identify novel signature for detection of coronary artery…
CAMBRIDGE, Mass., Sept. 27, 2021 (GLOBE NEWSWIRE) — Ring Therapeutics today announced that Fierce Biotech…
Klisyri has been approved for the treatment of actinic keratosis by the UK Medicines and…